Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur Rev Med Pharmacol Sci ; 24(23): 12516-12521, 2020 12.
Article in English | MEDLINE | ID: mdl-33336771

ABSTRACT

OBJECTIVE: The coronavirus disease 2019 (COVID-19) pandemic has significantly affected health care organizations globally. Many aspects of this disease, as well as the risks for patients treated with multiple drug regimens to control severe COVID-19, are unclear. During emergency surgery for SARS-CoV-2-positive patients, the risk of SARS-CoV-2 exposure and transmission to the surgical staff has yet to be determined. PATIENTS AND METHODS: In this report, we describe a SARS-CoV-2-positive patient with severe respiratory syndrome treated with multiple doses of IL-6 inhibitors who presented with a perforated duodenal ulcer and underwent emergency surgery. During and after surgery, we tested for SARS-CoV-2 at the ulcer site and in the peritoneal fluid. RESULTS: The history of the patient allows for two possible interpretations of the pathogenesis of the duodenal ulcer, which could have been a stress ulcer, or a gastrointestinal ulcer associated to the use of IL-6 inhibitors. We also noticed that the ulcer site and peritoneal fluid repeatedly tested negative for SARS-CoV-2. Therefore, we reviewed the pertinent literature on gastrointestinal bleeding in patients with COVID-19 and on SARS-CoV-2 detection in the peritoneal fluid of surgical patients and discussed possible prevention strategies for bleeding and the actual risk of infection for the surgical staff. CONCLUSIONS: The first implication of this case is that the relation between repeated administration of IL-6 inhibitors and upper gastrointestinal bleeding and perforation must be investigated, and that the threshold for administering prophylactic proton pump inhibitors therapy should be carefully considered for patients with severe COVID-19. The second implication is that further testing should be performed on the peritoneal fluid of COVID-19 patients undergoing emergency surgical procedures to clarify the discordant results for the presence of SARS-CoV-2 in the peritoneal cavity and the possible risk of transmission to the surgical staff.


Subject(s)
Antibodies, Monoclonal, Humanized/adverse effects , COVID-19 Drug Treatment , Duodenal Ulcer/surgery , Peptic Ulcer Hemorrhage/surgery , Peptic Ulcer Perforation/surgery , Stress, Physiological , Aged , Ascitic Fluid/chemistry , Ascitic Fluid/virology , COVID-19/physiopathology , COVID-19 Nucleic Acid Testing , Duodenal Ulcer/virology , Humans , Male , Peptic Ulcer Hemorrhage/virology , Peptic Ulcer Perforation/virology , RNA, Viral/analysis , SARS-CoV-2
2.
Ann Surg ; 272(3): e253-e256, 2020 09 01.
Article in English | MEDLINE | ID: mdl-32568751

ABSTRACT

Multiple tissue samples were obtained during emergent abdominal surgery in 4 patients with coronavirus disease 2019 (COVID-19) to examine for tissue involvement by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first patient underwent a laparoscopic cholecystectomy for gallbladder empyema and died from severe respiratory failure. The second patient with Crohn disease underwent emergent laparotomy for a perforation in the terminal ileum and recovered. The third patient underwent an open appendectomy and recovered. The fourth patient underwent emergent laparotomy for a perforated peptic ulcer and died from sepsis. Although the SARS-CoV-2 RNA was found in the feces of 3 patients and in the duodenal wall of the patient with perforated peptic ulcer, real time reverse transcriptase polymerase chain reaction (RT-PCR) examination of abdominal fluid was negative for the virus. The RT-PCR did not detect viral RNA in the wall of small intestine, appendix, gallbladder, bile, liver, and urine. Visceral fat (omentum) and abdominal subcutaneous fat of 4 patients were also not infected with the SARS-CoV-2. Although this limited experience did not show direct involvement of abdominal fluid and omentum, assessment in large series is suggested to provide answers about the safety of abdominal surgery in patients with COVID-19.


Subject(s)
Appendicitis/surgery , COVID-19/diagnosis , Cholecystitis/surgery , Peptic Ulcer Perforation/surgery , Peritonitis/surgery , SARS-CoV-2/isolation & purification , Adult , Aged , Appendicitis/virology , COVID-19/complications , COVID-19/surgery , COVID-19 Nucleic Acid Testing , Cholecystitis/virology , Female , Humans , Male , Peptic Ulcer Perforation/virology , Peritonitis/virology , Reverse Transcriptase Polymerase Chain Reaction
3.
Med J Malaysia ; 72(4): 244-245, 2017 08.
Article in English | MEDLINE | ID: mdl-28889137

ABSTRACT

Abdominal pain is one of the common presentations in severe dengue infection. We report a rare case of perforated gastric ulcer in a young man diagnosed with severe dengue infection and the challenges we faced in managing this patient. Perforated gastric ulcer need to be considered if there are signs of peritonitis and persistent abdominal pain that does not conform to the natural history of dengue. Proper imaging and early surgical intervention in perforated gastric ulcer is vital in preventing further complication and reducing the risk of mortality.


Subject(s)
Dengue/complications , Peptic Ulcer Perforation/etiology , Adult , Humans , Male , Peptic Ulcer Perforation/diagnostic imaging , Peptic Ulcer Perforation/surgery , Peptic Ulcer Perforation/virology , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...